You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ovarian neoplasm

Showing 1 - 25 of 5,252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

Not yet recruiting
  • Ovarian Cancer
  • +5 more
  • MIRRORS Protocol
  • Standard Open Cytoreductive Surgery
  • (no location specified)
Jul 17, 2023

Ovarian Tumor Epithelial Trial (acute normovolemic hemodilution (ANH), acute hypervolemic hemodilution (AHH))

Completed
  • Ovarian Neoplasm Epithelial
  • acute normovolemic hemodilution (ANH)
  • acute hypervolemic hemodilution (AHH)
  • (no location specified)
Oct 21, 2023

Patients With Low Grade Ovarian or Peritoneal Tumors

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed

Completed
  • Ovarian Neoplasm
  • +4 more
    • (no location specified)
    Aug 22, 2022

    Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

    Completed
    • Carcinoma
    • +12 more
    • Ocoxin-Viusid
    • Havana, Cuba
      National Institute of Oncology and Radiobiology (INOR)
    Jul 5, 2022

    Ovarian Tumor Trial in United States (Dostarlimab, Bevacizumab, Niraparib)

    Completed
    • Ovarian Neoplasm
    • Birmingham, Alabama
    • +9 more
    Feb 20, 2023

    Breast Cancer, Ovarian Tumor, Pain Trial in Albuquerque (Omega-3 fatty acid, Placebo, Paclitaxel)

    Completed
    • Breast Cancer
    • +2 more
    • Omega-3 fatty acid
    • +2 more
    • Albuquerque, New Mexico
    • +1 more
    Oct 4, 2022

    Malignant Ovarian Tumor, Ovarian Carcinoma Trial in Houston (Dynamic Enhanced CT, Magnetic Resonance Imaging, Positron Emission

    Recruiting
    • Malignant Ovarian Neoplasm
    • Ovarian Carcinoma
    • Dynamic Enhanced CT
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Ovarian Tumor Epithelial, Ovarian Cancer, Fallopian Tube Tumors Trial in India (Oregovomab, Paclitaxel, Carboplatin)

    Not yet recruiting
    • Ovarian Neoplasm Epithelial
    • +4 more
    • Oregovomab
    • +3 more
    • Visakhapatnam, Andhra Pradesh, India
    • +7 more
    Dec 7, 2022

    Endocrine Disruptors and Life STILe in Breast Cancer Development

    Recruiting
    • Breast Cancer
    • +5 more
      • Roma, Italy
        Alessandra Fabi
      Feb 25, 2023

      Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

      Recruiting
      • Carcinoma, Ovarian Epithelial
      • +8 more
      • AB-1015
      • Iowa City, Iowa
        U. of Iowa Health Care
      Jan 30, 2023

      Ovarian Cancer, Tumor, Ovarian, Ovarian Tumor Trial in Xi'an (chemo, targeted therapeutics, immunotherapy, IFRT, IMRT or SBRT)

      Recruiting
      • Ovarian Cancer
      • +16 more
      • chemotherapy, targeted therapeutics, immunotherapy
      • IFRT, IMRT or SBRT
      • Xi'an, Shaanxi, China
        The First Affiliated Hospital of Xi'an Jiao Tong University
      Sep 25, 2021

      Improved Diagnosis of Ovarian Cancer

      Recruiting
      • Ovarian Neoplasms
      • +6 more
        • Aarhus, Denmark
          Department of Gynaecology and Obstetrics, Aarhus University Hosp
        May 1, 2023

        Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

        Not yet recruiting
        • Ovarian Cancer
        • Houston, Texas
          MD Anderson Cancer Center
        Oct 9, 2023

        Distress, Anxiety and Psychosexual Health in BOT

        Recruiting
        • Ovarian Neoplasm Epithelial Borderline
        • questionnaire
        • Jette, Brussels, Belgium
          Universitair Ziekenhuis UZBrussel
        Oct 18, 2021

        Sarcoma, Ovarian Tumor, CNS Tumor Trial in Villejuif (Pembrolizumab)

        Active, not recruiting
        • Sarcoma
        • +6 more
        • Villejuif, France
          Gustave Roussy Cancer Campus
        Mar 28, 2022

        Sub-type Specific Genomic Mutations in sBOTs

        Recruiting
        • Ovarian Neoplasm Epithelial
        • genomic mutations study
        • Jette, Brussels, Belgium
          Universitair Ziekenhuis UZBrussel
        Oct 18, 2021

        Ovarian Cancer, Drug Related Tumor/Cancer Trial (secondary cytoreductive surgery, chemo)

        Not yet recruiting
        • Ovarian Cancer
        • Drug Related Neoplasm/Cancer
        • (no location specified)
        Jan 28, 2023

        Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

        Recruiting
        • Ovarian Cancer
        • +68 more
        • Phoenix, Arizona
        • +8 more
        Aug 18, 2022

        Ovarian Cancer, Malignant Tumor of Uterus Trial in New York (Sacituzumab, Cisplatin)

        Not yet recruiting
        • Ovarian Cancer
        • Malignant Neoplasm of Uterus
        • New York, New York
          Icahn School of Medicine at Mount Sinai Division of Hematology a
        Sep 14, 2023

        Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

        Recruiting
        • Advanced Malignant Solid Neoplasm
        • +7 more
        • Atlanta, Georgia
        • +2 more
        Nov 3, 2022

        Ovarian Tumor, Uterine Tumor Trial in Winston-Salem (Informational Intervention, Questionnaire Administration, Telephone-Based

        Completed
        Has Results
        • Ovarian Neoplasm
        • Uterine Neoplasm
        • Informational Intervention
        • +2 more
        • Winston-Salem, North Carolina
          Wake Forest University Health Sciences
        Nov 5, 2021

        Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

        Active, not recruiting
        • Fallopian Tube Clear Cell Adenocarcinoma
        • +22 more
        • Laboratory Biomarker Analysis
        • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
        • Rochester, Minnesota
          Mayo Clinic
        Oct 7, 2022

        Malignant Tumor of Ovary, Malignant Tumor of Fallopian Tube, Malignant Tumor of Peritoneum Trial in Charlotte, Cleveland

        Completed
        • Malignant Neoplasm of Ovary
        • +2 more
        • Diagnostic laparoscopy
        • Charlotte, North Carolina
        • +1 more
        Mar 11, 2022

        BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

        Recruiting
        • BRCA1 Gene Mutation
        • +19 more
        • Laboratory Biomarker Analysis
        • Pembrolizumab
        • New Brunswick, New Jersey
        • +1 more
        Nov 16, 2022